CAMBRIDGE, Mass., May 12, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced today the appointment of Nic G. Scalfarotto, D.V.M., Vice President of Regulatory Affairs. Prior to joining Momenta, Dr. Scalfarotto was most recently a Principal at Strategic Regulatory Consulting, L.L.C., where he provided contractual and consultative regulatory services to pharmaceutical, biotechnology, and other related industries, and Vice President, Global Regulatory Affairs and Clinical Quality Assurance at Eurand Pharmaceuticals, Inc.
